Ondansetron for intravenous use: New recommendations for the maximum single intravenous dose in adults


Intravenous news: MHRA report “There is new guidance for intravenous use of ondansetron in relation to: repeat dosing for all adults; dosing for prevention of chemotherapy-induced nausea and vomiting in patients age 75 years or older; and dilution and administration for patients age 65 years or older”.

Main page


Leave A Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.